Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Skin Picking Disorder and Other Body-Focused Repetitive Behaviors: Current and Emerging Therapies

Description

The presentation focuses on skin picking disorder and other body-focused repetitive behaviors (BFRBs), discussing the complexity of these conditions which are often underestimated as mere bad habits. These disorders, including dermatillomania and trichotillomania, significantly impact individuals' lives, causing shame, isolation, and physical damage. Current and emerging therapies include antidepressants, with studies showing efficacy at higher doses, and more recent options like N-acetylcysteine, which has demonstrated good results in symptom reduction. Behavioral therapies, particularly habit reversal training, are emphasized as integral in treatment, aiding patients in developing awareness and alternative responses to compulsive behaviors. Emerging treatments such as transcranial magnetic stimulation are also explored, showing promise but requiring further study for efficacy and duration of results. Diet may play a role in impulsivity, with studies suggesting a relationship between sugar intake and compulsive behaviors. Overall, the speaker advocates for better recognition, education, and support for patients suffering from BFRBs, emphasizing a multifaceted approach to treatment that combines medication, behavioral strategies, and lifestyle modifications.

View more

Conclusions

  • Body-focused repetitive behaviors (BFRBs) have severe, chronic impacts and are under-recognized, under-studied, and under-treated.
  • Current medications for skin picking and related disorders can require higher doses than typically prescribed for depression.
  • N-acetylcysteine has shown efficacy in reducing skin-picking symptoms and is well tolerated, suggesting it as a potential target for treatment.
  • Trichotillomania (hair pulling disorder) lacks FDA-approved pharmacological treatments, though various drug classes have been explored.
  • Combination therapies including sertraline and behavioral therapy may provide the best outcomes for trichotillomania.
  • Prescription stimulants can induce trichotillomania and similar conditions in certain patients, highlighting the need for careful monitoring.
  • Recent studies emphasize the importance of nutritional factors in managing BFRBs, linking high sugar and fat diets to increased impulsivity and compulsive behaviors.
  • Vitamin D supplementation has resulted in notable improvements for some patients with trichotillomania, suggesting a need for further research on nutritional contributions to mental health.
  • Psychopharmacology of trichotillomania (hair pulling disorder): an updated systematic review. McGuire JF, Ung D, Selles RR, Rahman O, Lewin AB, Murphy TK, Storch EA, Rothbart R, Stein DJ. PMID: 23452680 PMCID: PMC3745012 DOI: 10.1016/j.jaac.2012.12.020.
  • Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. McGuire JF, Ung D, Selles RR, Rahman O, Lewin AB, Murphy TK, Storch EA, Rothbart R, Stein DJ. Expert Opin Pharmacother. 2014 Dec;15(18):2709-19. doi: 10.1517/14656566.2014.972936.
  • N-acetylcysteine in the treatment of trichotillomania: a double-blind, placebo-controlled study. Jon E Grant, Brian L Odlaug, Suck Won Kim. Arch Gen Psychiatry. 2009 Jul;66(7):756-63. doi: 10.1001/archgenpsychiatry.2009.60.
  • The glutamate system may prove to be a beneficial target in the treatment of compulsive behaviors. J Am Psychiatry. 2023 May 1;180(5):348-356. doi: 10.1176/appi.ajp.20220737. Epub 2023 Feb 22.